Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response

BACKGROUND/AIMS: Entecavir is a potent nucleoside analogue with high efficacy and barrier for resistance. We aimed to investigate the long-term efficacy and viral resistance rate of entecavir and explore the factors associated with virologic response, including quantitative hepatitis B surface antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Ju-Yeon, Sohn, Won, Sinn, Dong-Hyun, Gwak, Geum-Youn, Paik, Yong-Han, Choi, Moon Seok, Koh, Kwang Cheol, Paik, Seung Woon, Yoo, Byung Chul, Lee, Joon Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511938/
https://www.ncbi.nlm.nih.gov/pubmed/27809454
http://dx.doi.org/10.3904/kjim.2016.096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511938/
https://www.ncbi.nlm.nih.gov/pubmed/27809454
http://dx.doi.org/10.3904/kjim.2016.096

Ejemplares similares